2022 / 03

Next Paper
DOI: 10.24075/brsmu.2022.030

ORIGINAL RESEARCH

Clinical and morphological features of non-small cell lung cancer in patients with different types of histological changes to the bronchial epithelium

Zavyalova MV1,2, Loos DM1, Pismenny DS1,2, Durova AA1, Pankova OV2, Rodionov EO2, Tuzikov SA1,2, Tashireva LA2, Perelmuter VM2
About authors

1 Siberian State Medical University, Tomsk, Russia

2 Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia

Correspondence should be addressed: Dmitry S. Pismenny
Kooperativny pereulok, 5, Tomsk, 634009, Russia; moc.liamg@yrtimd.yinnemsip

About paper

Author contribution: Pismenny DS — analysis of the literature and writing of the text; Rodionov EO, Tuzikov SA — surgery and tumor specimen collection; Pankova OV, Loos DM, Durova AA — morphological study; Tashireva LA — statistical processing of the data; Zavyalova MV, Perelmuter VM — concept and design, scientific editing of the manuscript.

Compliance with ethical standards: the study was approved by Ethical Review Board at the Siberian State Medical University (Protocol No. 5600 of 23 October 2017).

Received: 2022-05-04 Accepted: 2022-06-02 Published online: 2022-06-15
|
  1. Kaprin AD, Starinskij VV, Petrova GV, redaktory. Sostoyanie onkologicheskoj pomoshhi naseleniyu Rossii v 2017 g. M.: MNIOI im. PA Gercena — filial FGBU «NMIC radiologii» Minzdrava Rossii, 2018. Russian.
  2. Pankova OV, Perelmuter VM, Litvyakov NV, Denisov EV, Gerdt LV. Vzaimosvyaz' neoplasticheskix izmenenij s bazal'nokletochnoj giperplaziej bronxial'nogo ehpiteliya pri ploskokletochnom rake i adenokarcinome legkogo. Sibirskij onkologicheskij zhurnal. 2011; 5: 57–60. Russian.
  3. Pankova OV, Perelmuter VM, Tuzikov SA, Denisov EV. Pre- i neoplasticheskie izmeneniya bronxial'nogo ehpiteliya pri ploskokletochnom rake i adenokarcinome legkogo. Byulleten' sibirskoj mediciny. 2014; 13 (3): 100–10. Russian.
  4. Pankova OV, Perelmuter VM, Savenkova OV, Denisov EV, Vasilev SA, Skryabin NA, i dr. Osobennosti vospalitel'noj reakcii v slizistoj bronxa v uchastkax bazal'nokletochnoj giperplazii i ploskokletochnoj metaplazii na fone ploskokletochnogo raka legkogo. Sibirskij onkologicheskij zhurnal. 2012; 5: 28–33. Russian.
  5. Pankova OV, Perelmuter VM, Savenkova OV. Xarakteristika ehkspressii markerov proliferacii i regulyacii apoptoza v zavisimosti ot xaraktera disregeneratornyx izmenenij v ehpitelii bronxov pri ploskokletochnom rake legkogo. Sibirskij onkologicheskij zhurnal. 2010; 5: 36–41. Russian.
  6. Kerr KM. Preneoplastic and Preinvasive Lesions.Diagnostic Pulmonary Pathology. In: Cagle PT, Allen TC, Beasley MB editors. 2008; 519–26.
  7. Kerr KM, Popper HH. Pre-invasive lung lesions. Europen Respiratory Monograph. 2007; 12 (39): 37–63.
  8. Dacic S. Pulmonary Preneoplasia. Archives of pathology & laboratory medicine. 2008; 132 (7): 1073–8.
  9. Greenberg A, Yee H, Rom W. Preneoplastic lesions of the lung. Respiratory research. 2002; 3 (1): 1–10.
  10. Lantuejoul S, Salameire D, Salon C, Brambilla E. Pulmonary preneoplasia — sequential molecular carcinogenetic events. Histopathology. 2009; 54 (1): 43–54.
  11. Denisov EV, Schegoleva AA, Gervas PA, Ponomaryova AA, Tashireva LA, Boyarko VV, et al. Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression. Lung Cancer. 2019; 135: 21–28.
  12. Pankova OV, Denisov EV, Ponomaryova AA, Gerashchenko TS, Tuzikov SA, Perelmuter, VM. Recurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium. Tumor Biology. 2016; 37 (3): 3599–607.
  13. Pankova OV, Tashireva LA, Rodionov EO, Miller SV, Tuzikov SA, Pismenny DS, et al. Premalignant changes in the bronchial epithelium are prognostic factors of distant metastasis in nonsmall cell lung cancer patients. Frontiers in Oncology. 2021; 11: 771802. DOI: 10.3389/fonc.2021.771802.
  14. Pankova OV, Rodionov EO, Miller SV, Tuzikov SA, Tashireva LA, Gerashchenko TS, et al. Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non-small cell lung cancer (NSCLC) patients. Translational Lung Cancer Research. 2020; 9 (4): 988–99. DOI: 10.21037/tlcr-19-719.
  15. Hortobagyi GN, Connolly JL, D’Orsi CJ, Edge SB, Mittendorf EA, Rugo HS. The AJCC Cancer staging manual. Eight Edition: Springer Nature. 2017.
  16. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart. International Agency for Research on Cancer. Journal of Thoracic Oncology. 2015; 10 (9): 1243–60.
  17. Savenkova OV, Zavyalova MV, Bychkov VA, Choinzonov EL, Perelmuter VM. Svyaz' ehkspressii matriksnyx metalloproteinaz s morfologicheskoj geterogennost'yu, differencirovkoj opuxoli i limfogennym metastazirovaniem ploskokletochnoj karcinomy gortani. Sibirskij onkologicheskij zhurnal. 2015; 1: 51–58. Russian.
  18. Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Annals of oncology. 2015; 26 (2): 259–71.